Innovation and imitation,opportuniα×"ty and challenge
Asia-Pacific Pharma IP Leader summit201δ♠9---14th-15th NOV, B σ$δeijing CHINAOn March 19, 2019, the≠÷¶✘ World Intellectual Proper≤♠ty Organization (WIPO) published its ₽¶♥εglobal intellectual property rep ™ort 2018.Asian innovators filed more than half ♠✔of their internationa¶∏βl patent applications through WIPΩ×O for the first time in 20Ω©18, with significant growth in China, India an↕≠d South Korea, the report no÷"♣ted. As a technology-intensive$÷♣ industry, pharmaceutical industry attΩ aches great importance to patent applicatio₽εγn and intellectual property protection."λαIn recent years, the size o♥™f the global pharmaceutical market has m♠≤↓aintained a steady growth, with China,≠π©> South Korea, India and other e÷&merging markets presentin₹g a rapid growth momentum. Due to the diffe≠÷rent intellectual property policiesφφ≠↕ of different countries, the s•π ∑trategic layout of global intellectual property,©≥ the differences of pharmaλ$ceutical intellectual property policies of₹♥" Asia-pacific countries, the patent r♥λ<eview process, litiga>₽tion procedures and Generic drug patε π×ent strategy have gradually bec∏'✘"ome the hot spots of the γ§pharmaceutical intellectual properα¶λ→ty industry.In this context, the ±©★β2019 Asia-pacific Pharmaceutica§₹✘∏l IP Leader Summit will be held in × ≈€Beijing on November 14-15, and will attract morδ©♦e than 500 industry experts from ↓ domestic and foreign pharmaceutical≠✘ companies, biotechnology companies, go¥★σαvernments, associations, law firms, ≠π☆intellectual property agents and ot∏↓her companies to attend.Agenda Framework:Section £ 1:Interpretation of Policy: Development of Pha¶ε±↕rmaceutical IP under the New Legislatiβ ✘ve Landscape Section 2:Pharmaceutical R&D ♣∑₹∞Innovation and IP Protection -- ε₩♣Global VisionSection 3:Case Shaσπ↑ring of Pharmaceutical Pate$♦™↔nt Invalidity, Infringement, LitigationSec §tion 4:Opportunities and challe♠•nges for generics companies under the new >←•situation HOTSPOT:ü Medical →§Policy Interpretation under the Background o∏♣≈f Patent Law Amendmentü The innovation o•→✔♥f Judicial Mechanism Promo☆★ε$tes the Development of Pha•₽&rmaceutical Intellectual Propertyü In'↑£¥tellectual Property Management Experience in Mult•∞→inational Pharmaceutical Companies, Patent L≈≥βayout Strategy, Litigation ₽♣Strategyü he Data Protection Regulati♥♠ons of Drug Test—New Eraü Trade Secrets and§φ✔ Patent Layout in the Medical Fi×γσeldü Establishing The Internal Inte✔✔≥±llectual Property System uα₽←♥nder The New Legislative Landsca ←♥peü Opportunities and÷ ↑Ω Challenges of Pharmaceuα ™tical Enterprises under Patent Term Compen♠•'↔sation System--- Global Vision and Its Implφ£↔♦ications for Chinaü Latest Changes i±∞¥<n European Patent Applicat→×£ion and Review Proceduresü Analysi∏"s of Hot Cases of Recent Patent Invalidationü& σ 'nbsp; The Procedure of Ame≠₽✘εrican Pharmaceutical Patent litigationδ→∏ and its Enlightenment to Chinese Pharmaceu₽ λtical Enterprises ü A÷≤≈pplication techniques and pr≈λ'otection strategies for European and Amer®™Ωεican biomedical patentsü Changes i÷'☆n standards for creativ™•≤e review of patentsü European, American★∑•Ω and Japanese Medical Patent Examinat←¥δ∞ion Cases and its implications for Domest★☆®↕icPharmaceutical Companiesü Recent Hot P↓≠βatent Infringement Cases Analysisü The Straσγtegy of Indian Generic Dru≈&€€g Companies in R&D and Pre-PAü How to aλ∏ void the Patent Trap in Generic Drug Developmen¶≥≈tü The Strateg✔λy of Generic Drug Compani&ε↑es to Enter the European and American Marketsü"☆≤ Patentability in Europe£', the United States an₽ δd Chinaü Patent litig€✘ation in Europeü Doubts around the Un ≠♠ ified Patent Court (UPC) agreement and Brexitü&nb♣♣>✔sp; Second medical use patentsComp'↕osition of participantsγ↔: Summit highlights:10+ Hot tε♠©opic20+ Authoritative spee←✘ch5 0+ Industry media4 "↔™0+ BIC110+pharma company 500+專業(yè)參會(huì)₩₹嘉賓 ☆←₹§  ←®;  ↑§₹; Professional participantsOffic ial registration and consulta≈"₩tion channels:Contact₩♦ £:AnnPhone: 021-65650305Emaiβ↔★l:Marketing@zenseegroup.comhttp://en.zense•→egroup.com/p/510934/